Department of Cardiology, Shandong Shanxian Central Hospital, Shanxian, China.
Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5462-5470. doi: 10.26355/eurrev_201712_13936.
To investigate the relationship between miR-181a and cardiac hypertrophy and autophagy in rats with myocardial hypertrophy, and whether miR-181a regulates the autophagy through ATG5, thereby participating in the occurrence and development of myocardial hypertrophy.
The rat model of myocardial hypertrophy was established via the abdominal aortic coarctation. The expression of miR-181a in cardiac tissues was detected via reverse transcription-polymerase chain reaction (RT-PCR). The expressions of autophagy-related proteins, ATG5 and LC3II/LC3I, in cardiac tissues, were detected via Western blotting (WB). After the primary culture of myocardial cells in rats, they were stimulated via Angiotensin II (Ang II) to observe the effects of autophagy inhibitor 3-methyladenine (3-MA) and overexpression of ATG5 on the expression of hypertrophic genes in myocardial cells, respectively. The expressions of autophagy-related proteins ATG5 and LC3II/LC3I were detected via WB, the autophagic rate was observed via flow cytometry and the changes in autophagic vacuoles of myocardial cells were observed using the transmission electron microscope. The changes in mRNA and protein expressions of ATG in myocardial cells were observed after the overexpression of miR-181a or the inhibition of miR-181a activity. The changes in miR-181a and the expression of hypertrophic genes in myocardial cells after Ang II stimulation were observed via RT-PCR.
In rats with myocardial hypertrophy, the cardiac autophagy was increased and the expression of miR-181a in hypertrophic myocardium was downregulated. 3-MA inhibited the ATG5-induced autophagy and improved the Ang II-induced myocardial hypertrophy, while the overexpression of ATG5 enhanced the myocardial autophagy and the expression of hypertrophic genes. MiR-181a regulated the ATG5-induced myocardial autophagy, and its downregulation mediated the Ang II-induced myocardial hypertrophy.
The enhancement of ATG5-induced myocardial autophagy mediates the Ang II-induced myocardial hypertrophy. ATG5 is the target gene of miR-181a, it can regulate the myocardial autophagy via ATG5, thus mediating the Ang II-induced myocardial hypertrophy.
探讨 miR-181a 与大鼠心肌肥厚及自噬的关系,以及 miR-181a 是否通过 ATG5 调节自噬,从而参与心肌肥厚的发生发展。
采用腹主动脉缩窄法建立大鼠心肌肥厚模型,采用逆转录聚合酶链反应(RT-PCR)检测心肌组织中 miR-181a 的表达。采用 Western blot(WB)检测心肌组织中自噬相关蛋白 ATG5 和 LC3II/LC3I 的表达。原代培养大鼠心肌细胞后,用血管紧张素 II(Ang II)刺激,观察自噬抑制剂 3-甲基腺嘌呤(3-MA)和过表达 ATG5 对心肌细胞肥大基因表达的影响。采用 WB 检测自噬相关蛋白 ATG5 和 LC3II/LC3I 的表达,流式细胞术观察自噬率,透射电镜观察心肌细胞自噬小体的变化。过表达 miR-181a 或抑制 miR-181a 活性后观察心肌细胞中 ATG 的 mRNA 和蛋白表达变化。用 Ang II 刺激观察 miR-181a 变化及心肌细胞肥大基因表达变化。
在心肌肥厚大鼠中,心肌自噬增加,肥厚心肌中 miR-181a 的表达下调。3-MA 抑制 ATG5 诱导的自噬,改善 Ang II 诱导的心肌肥厚,而过表达 ATG5 增强心肌自噬和肥大基因的表达。miR-181a 调节 ATG5 诱导的心肌自噬,其下调介导 Ang II 诱导的心肌肥厚。
增强 ATG5 诱导的心肌自噬介导 Ang II 诱导的心肌肥厚。ATG5 是 miR-181a 的靶基因,可通过 ATG5 调节心肌自噬,从而介导 Ang II 诱导的心肌肥厚。